Generics Industry News Search
 |
|
|
|
|
|
|
October 2005 News Archive |
|
|
| |
|
Lannett Co., a maker of generic drugs, said Monday that it received Food and Drug Administration approval to market Danazol capsules...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Mylan Laboratories Inc. today announced that Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
The Supreme Court on Tuesday rejected an appeal from a generic drug company over the patent for the antidepressant Zoloft, in a case that sought to speed up development of a cheaper substitute....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Agvar Chemicals Inc. announced today that it has joined with Ranbaxy Laboratories Limited and Ranbaxy Pharmaceuticals, Inc. as plaintiffs in a lawsuit against Barr Laboratories, Inc. and Teva Pharmaceuticals USA, Inc. ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Barr Laboratories, Inc., a subsidiary of Barr Pharmaceuticals, Inc., today announced that it is challenging the patents protecting Boehringer Ingelheim Pharmaceuticals, Inc.'s Mirapex(R) (Pramipexole Dihydrochloride) Tablets,...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Pfizer Inc said today the United Kingdom's High Court of Justice has upheld the exclusivity of the main patent covering atorvastatin,...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Roche Holding AG said it would take 2-3 years for a company to make a generic version of Tamiflu, ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Teva Pharmaceutical Industries Ltd. announced today that trial examiners in the Japanese Patent Office have granted judgment in favor of Teva with regard to Sankyo’s Patent No. 3463875 in Japan. ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Boston Scientific Corporation announced today that a Dutch appeals court yesterday overturned a lower court ruling and reinstated an injunction against the manufacture, use or sale in the Netherlands...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Actavis Group, the international generic pharmaceuticals company, announced today that it has agreed to acquire the human generics business of the US listed pharmaceutical company, Alpharma Inc., for a total consideration of US$810 million in cash....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Barr Laboratories, Inc., a subsidiary of Barr Pharmaceuticals, Inc., today announced that it is challenging the patents protecting Janssen Pharmaceutica Products, L.P.'s Risperdal(R) M-Tab(R) (Risperidone Orally Disintegrating Tablets) 0.5mg, 1mg & 2mg....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Lannett Company, Inc., a manufacturer of generic pharmaceuticals, today announced that it has received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Pilocarpine HCl tablets....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Wyeth and Teva Pharmaceutical Industries Ltd. today announced that they have reached agreement on the principal terms of a settlement of the U.S. patent infringement litigation pertaining to Teva’s generic version...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
BioGenex has emerged victorious after more than two-and-a-half years of litigation in federal court against Ventana Medical Systems ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
AstraZeneca has received a notice from Ranbaxy Pharmaceuticals Inc. that Ranbaxy Laboratories Limited has submitted an Abbreviated New Drug Application (ANDA) for esomeprazole magnesium delayed-release capsules,...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Andrx Corporation today announced that it has a pending abbreviated new drug application (ANDA) with the United States Food and Drug Administration (FDA) for generic versions of Cardizem(R) LA (diltiazem HCl extended-release tablets), ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Roche reiterates willingness to enter discussions with governments and other manufacturers on the production of Tamiflu for emergency pandemic use....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Connetics Corporation, a specialty pharmaceutical company focused on dermatology, announced today that it has filed a patent infringement lawsuit under paragraph IV of the Hatch-Waxman Act against Agis Industries Ltd., ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Par Pharmaceutical Companies, Inc. today announced that its marketing partner, Three Rivers Pharmaceuticals, has been granted tentative approval by the U.S. Food and Drug Administration for its Abbreviated New Drug Application for ribavirin 200 mg,...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Shire Pharmaceuticals Group plc announces that its subsidiary Shire Laboratories Inc. has filed a lawsuit in the U.S. District Court of the Southern District of New York against Barr Laboratories, Inc. and Impax Laboratories, ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Teva Pharmaceutical Industries Ltd. announced today that the U.S. District Court for the District of Columbia has granted the Company’s request to enjoin the U.S. Food and Drug Administration...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Caraco Pharmaceutical Laboratories, Ltd. announced today that the United States District Court for the Eastern District of Michigan granted Caraco's motion for non- infringement on its generic version of Ultracet(R)....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
MN Pharmaceuticals today announced that it has signed an agreement with PAR Pharmaceuticals based in New Jersey – U.S., to develop and market generic version of injectable pharmaceuticals....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Forest Laboratories, Inc., an international pharmaceutical manufacturer and marketer, and its partner H. Lundbeck A/S of Denmark, ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
IVAX Corporation receives final Mutual Recognition Procedure (MRP) approval from the Medicine and Healthcare Products Regulatory Agency (MHRA) for Fluticasone nasal spray in eleven countries across Europe. ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Aurobindo Pharma Limited is pleased to announce that U.S. Food Drug Administration (US FDA) has tentatively approved its Sertraline Hydrochloride ANDA for Tablets 25 mg (base), 50 mg (base) and 100 mg (base)....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Teva Pharmaceutical Industries Ltd. today announced that the U.S. Food and Drug Administration has granted final approval for the Company’s ANDA for Glipizide and Metformin Hydrochloride Tablets, ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
IVAX Corporation, in response to questions, announced today that it is challenging the patents protecting AstraZeneca’s Pulmicort™ Respules™ (budesonide inhalation suspension). ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Ranbaxy Laboratories Limited announced today the status of issues relating to the 180 day exclusivities for two of the largest cholesterol-lowering agents marketed in the US healthcare market....
|
| |
|
|
Read more >>
|
| |
|
|
|
|
|
Contribute
If you would like to contribute or publish your
company press releases at GenericsWeb, please
email us.
|
Home
